OCT 16, 2018 10:37 PM PDT

Anti-Venomous Plant Compound

WRITTEN BY: Nouran Amin

According to a study published in PLOS Neglected Tropical Diseases, researchers at the Institute Butantan, São Paulo, Brazil, have discovered a flavonoid found in plants to be effective in acting as antivenom compound from the South American pit viper Bothrops jaraca.

The viper is most commonly found northern Argentina, southern Brazil and northeastern Paraguay. It is an abundant species and the large cause of snakebites. Their venom is composed of a mixture of complex proteins that disrupt chemical reactions inside cells.

Being bitten by the snake, can lead to site swelling, blistering, severe hypotension and systemic bleeding from the skin, nose, and gums--eventually leading to shock, intracranial hemorrhage, or renal failure. More than often, the venom of the viper causes proteolytic, coagulant and hemorrhagic effects. Uniquely, these properties are based on a peptide found in their venom which is presently being used for drug development in the treatment of heart failure and hypertension.

Image via RisingKashmir.com

The flavonoid identified is called ‘rutin’ which can protect envenomed mice from bleeding and inflammation complications. Current anti-venoms can treat the major issues arising from a snake bite however, it cannot treat common saucer implications of the bite including bleeding.

Chemical Structure of Rutin. Image via 'Rutin' from Wikipedia

Existing anti-venoms can treat the major effects of the snake bites however, there are no known therapies for common secondary complications, such as the inability to stop the bleeding.

Results of the research were derived from studies on mouse models injected with both venom and rutin. The mice were than further analyzed for the physiological triggers of venom to better understand the effects rutin on pathophysiological events triggered by the venom. The research findings ‘indicates that rutin has a great potential as an ancillary drug in concert with antivenom therapy to treat snakebites, particularly in countries where antivenom availability is scarce.’

 

Source: Drug Target Review

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
SEP 07, 2018
Videos
SEP 07, 2018
The Therapeutic Potential of Venoms
Over 220,000 species, around 15 percent of the world's described animals, are known to be venomous....
SEP 20, 2018
Drug Discovery
SEP 20, 2018
Chemotherapeutic Drugs Battle Antimalarial Drug Resistance
According to the latest research published in the journal Nature Communications, researchers discovered that chemotherapeutic drugs can increase the effect...
SEP 23, 2018
Cell & Molecular Biology
SEP 23, 2018
Insulin may be a new Colitis Treatment
Insulin is a necessary medicine for diabetics, but new work shows that insulin may also be used to treat chronic bowel inflammation....
NOV 15, 2018
Drug Discovery
NOV 15, 2018
Anti-inflammatory Drug Works Like an Inhibitor
At Karolinska Institutet in Sweden, a team of scientists from multiple disciplines have worked together to develop an inflammation inhibitor. The new anti-...
DEC 05, 2018
Videos
DEC 05, 2018
Male Contraceptive Gel is in Clinical Trials
Researchers have started a clinical trial involving 420 participants to test the efficacy of a male contraceptive gel....
JAN 16, 2019
Genetics & Genomics
JAN 16, 2019
Gene Therapy for a Leading Cause of Infant Death is Closer to Market
New treatments for some diseases can have extremely high price tags. One example is Zolgensma, which might cost $5 million per patient....
Loading Comments...